ROSA NARDO: Open Payments
NPI 1063921104 · MARIETTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,527 in 85 payments from 15 companies in 2025. Trend: 2023 $725 · 2024 $681 · 2025 $1,527
Food & beverage: $1,527
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $502 |
| PFIZER INC. | 22 | $352 |
| Janssen Biotech, Inc. | 6 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $113 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
| Madrigal Pharmaceuticals | 4 | $85 |
| Ardelyx, Inc. | 2 | $51 |
| GENZYME CORPORATION | 2 | $40 |
| QOL Medical, LLC | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
Products named: RINVOQ, VELSIPITY, XELJANZ, TREMFYA, XIFAXAN, CREON, REZDIFFRA, LINZESS.
Industry payments across OH — which companies pay providers there.
